Skip to content

Effects of Whey Protein Pre-meals on Post-prandial Glucose

Effects of Whey Protein Pre-meals on Post-prandial Glucose

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05112146
Enrollment
16
Registered
2021-11-08
Start date
2018-08-20
Completion date
2018-08-29
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetic State

Brief summary

The aim of this project was to determine if an administration of either 10 g of whey protein isolate or 10 g of whey protein microgels 30 or 10 min before a standard meal could reduce postprandial glucose response in obese subjects.

Detailed description

Monocentric, controlled, randomized, open, complete cross-over study design where participants will take 2 test products or water (negative control) at 2 different time points. The targeted population will be 16 completely healthy males and females at risk for pre-diabetes. Primary objective: To quantify the effects of whey protein pre-meals administrated at 30 or 10 min before a meal on post-prandial glucose in the interstitial tissue, as compared to water as negative control. Secondary objective: To compare glucose response of the different pre-meals (water, whey protein isolate, whey protein micelles).

Interventions

DIETARY_SUPPLEMENTWhey protein isolate

Oral administration

DIETARY_SUPPLEMENTWhey protein microgel

Oral administration

DIETARY_SUPPLEMENTWater

Oral administration

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female participant * Age between 40 and 65 years * BMI higher than 27.0 kg/m2 * Sedentarity (no more than 30 min of walk per day). * Able to understand and sign an informed consent form

Exclusion criteria

* Any known metabolic disease including diabetes or chronic drug intake (aspirin, vitamin C and mineral supplements, steroids, protease inhibitors, antidepressants, anxiolytic, or antipsychotics…) possibly impacting (to the opinion of the medical doctor): * The digestion or absorption of nutrients * The postprandial glucose response * Major medical/surgical event requiring hospitalization in the last 3 months, to the opinion of the medical doctor * Known allergy and intolerance to products components * Medically known cutaneous hypersensitivity to adhesives and plasters * Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer. * Smokers * Volunteer who cannot be expected to comply with the protocol * Subject having a hierarchical link with the research team members

Design outcomes

Primary

MeasureTime frameDescription
Post-prandial glucoseHour 0 to hour 2 after standard meal consumptionIncremental area under the curve

Secondary

MeasureTime frameDescription
C max glucoseHour 0 to hour 2 after standard meal consumptionIncremental Cmax
T max glucoseHour 0 to hour 2 after standard meal consumptionIncremental Tmax

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026